Venture Capital Investment | Plutus Investment Group

About Us

A team of industry experts with a successful investment experience

Our Philosophy

Investing in Tomorrow’s Champions

Founded in 2021 by a seasoned group of entrepreneurs, investors and industry veterans, Plutus Investment Group  is a family office that focuses on backing startups in Europe and the USA.

We’re looking for leaders with a drive and a strong vision. While we only invest in a handful of companies a year, it means we can provide the time, the energy and the capital for those companies to succeed and become a game changers

About

Our Management Team

Our team combined investment experience exceeds 60 years

MOHAMMED JAMAL

Founder – Chief Executive Officer

Bio

Mr Jamal has over 18 years of experience in structuring, placement, trading, private equity and liquid Investing. Mr Jamal started his career at Morgan Stanley in the structured credit team in 2003. In 2009 Mr Jamal moved to Resource America a $15Bn credit fund to lead their business in Europe.
In 2012 Mr Jamal founded Molton Street Capital a London based CLO, CDO and ABS trading company that traded  over $3Bn.
In 2016 Mr Jamal co-founded Forepont Capital Group, a leading life science Venture Capital fund with office in London, New York and Paris
Mr Jamal invested in more than 20 companies since 2012 and made multiple successful exits.
Mr Jamal holds a Masters degree in Applied Mathematics and Computer Sciences from Ecole Centrale Paris (top French “ Grande Ecole” ) and an advanced degree (DEA) in Finance and Economics from La Sorbonne University in Paris.

STEVE WEATHERHEAD

Chief Operating Officer
( Non-Executive )

Bio

Mr Weatherhead started in structured finance in 1995 in Australia.  Mr Weatherhead joined Ambac in 2000 providing financial guarantees to a broad range of European securitisation issuance. In 2003 Mr Weatherhead joined Morgan Stanley to run corporate securitisation, and became the European Head of Credit for the bank’s principal investment business. Since leaving Morgan Stanley, Mr Weatherhead has held senior positions in securitisation, structuring and reinsurance at insurance companies L&G and Aviva.
Mr Weatherhead has also been a non-executive credit committee member of the AE Global Investment Solutions credit fund since 2014

DR CLAIRE BUTTON

Head of Business Development

Bio

Doctor Claire holds a BSc in medical Biochemistry From king’s college London and a PhD in Immunopharmacology from the University Of Liverpool. As an investor, board member, and company CEO, Dr Claire is a leader at executive levels. She has been appointed as the head of healthtech investments as Director of wealth management firm, and has been actively investing globally with Family Offices and Sovereign Wealth Funds. Dr Claire is also a Member of medtech committee for VC fund and is an angel investor in techbio ventures. Her previous CEO roles included restructuring and leading a neurotech business across Nordic countries, Japan, and UK,raising funds, pivoting strategy, forming partnerships, and building teams. Dr Claire is also a presenter, mentor and judge for accelerator programmes, including KQ Labs, BIA Pulse, MedCity and Wellcome Trust.

The Geniuses Behind Our Work

Board Members

We have an outstanding Board Of Directors with an extended expertise in key industries 

MOHAMMED JAMAL

Chief Executive Officer ( London )

Bio

Mr Jamal has over 18 years of experience in structuring, placement, trading, private equity and liquid Investing.
Mr Jamal started his career at Morgan Stanley in the structured credit team in 2003. In 2009 Mr Jamal moved to Resource America a $15Bn credit fund to lead their business in Europe.
In 2012 Mr Jamal founded Molton Street Capital a London based CLO, CDO and ABS trading company that traded  over $3Bn.
In 2016 Mr Jamal co-founded Forepont Capital Group, a leading life science Venture Capital fund with office in London, New York and Paris
Mr Jamal invested in more than 20 companies since 2012 and made multiple successful exits.
Mr Jamal holds a Masters degree in Applied Mathematics and Computer Sciences from Ecole Centrale Paris (top French “ Grande Ecole” ) and an advanced degree (DEA) in Finance and Economics from La Sorbonne University in Paris.

STEVE WEATHERHEAD

Chief Operating Officer (London)

Bio

Mr Weatherhead started in structured finance in 1995 in Australia.  Mr Weatherhead joined Ambac in 2000 providing financial guarantees to a broad range of European securitisation issuance. 
In 2003 Mr Weatherhead joined Morgan Stanley to run corporate securitisation, and became the European Head of Credit for the bank’s principal investment business.
Since leaving Morgan Stanley, Mr Weatherhead has held senior positions in securitisation, structuring and reinsurance at insurance companies L&G and Aviva.
Mr Weatherhead has also been a non-executive credit committee member of the AE Global Investment Solutions credit fund since 2014

DR MICHELLE TEMPEST

Venture Partner – Life Science (London)

Bio

Dr Tempest is partner in a strategic management consultancy company, Candesic, with global clients ranging from investors to large operators in specialist sectors – life sciences, healthcare, social care, digital and education . 

She was a hospital doctor for over a decade and still teaches medical students at Cambridge University. 

She’s author of a book about technology and the human brain –  ‘Big Brain Revolution: Artificial Intelligence – Spy or Saviour’, a best seller on Amazon for AI in 2020. 

She is an angel investor and chairs the EU advisory board for Citadel, a global Laboratory and diagnostics information system.

She is an MD from Cambridge University

DR CLAIRE BUTTON

Head of Business Development

Bio

Doctor Claire holds a BSc in medical Biochemistry From king’s college London and a PhD in Immunopharmacology from the University Of Liverpool. As an investor, board member, and company CEO, Dr Claire is a leader at executive levels. She has been appointed as the head of healthtech investments as Director of wealth management firm, and has been actively investing globally with Family Offices and Sovereign Wealth Funds. Dr Claire is also a Member of medtech committee for VC fund and is an angel investor in techbio ventures. Her previous CEO roles included restructuring and leading a neurotech business across Nordic countries, Japan, and UK,raising funds, pivoting strategy, forming partnerships, and building teams. Dr Claire is also a presenter, mentor and judge for accelerator programmes, including KQ Labs, BIA Pulse, MedCity and Wellcome Trust.

YUSUF MERCHANT

Venture Partner – Technology (London)

Bio

Yusuf Merchant joined Plutus Impact in September 2022 with extensive experience in structuring, originating and managing the risks of the largest cash and derivative deals at MUFG and Lloyds Banking Group. He has served as a Director at MUFG Securities, MUFG Bank and Lloyds Banking Group. Over his career, Yusuf has originated over GBP 15bn of Structured Transactions and Asset-Backed securities across social housing, small-medium enterprise, infrastructure and property. Yusuf is a trained engineer, having worked in Australia, Germany and Taiwan before joining the City of London as a banker. Yusuf has joined the Plutus Impact team to manage the [Add what you would like to here]. Yusuf is also a passionate entrepreneur and investor having founded his own Private Equity and Venture Capital Firm, Emir Group, in 2013 which has been developed to offer acceleration and incubation services to smaller seed and capital start- ups in the Healthcare, Life Sciences, Micro-Finance and Renewable Technology sectors. Yusuf received his CFA and Certificate in Islamic Finance in 2013 and Certificate of Quantitative Finance in 2007. He has a Bachelor of Electrical and Electronic Engineering from the University of Western Australia and a Master of Finance from Macquarie University in Sydney.

NADIR-BENOIT ELBIED

Venture Partner – Credit & Fintech (New York)

Bio

Mr. Elbied has close to 20 years of capital markets experience, holding senior roles across both banking and trading with extensive experience analyzing, structuring, negotiating, and distributing complex financial instruments across a diverse range of asset classes.

Mr. Elbied founded Mont Blanc Capital Partners (“MBCP”) in May 2016 to invest opportunistically in illiquid and/or special situations through private debt or equity.

Mr. Elbied started his career at Greenwich Capital Markets (an affiliate of the Royal Bank of Scotland) in 1999, where he was a core member of the Structured Products Group. 

In 2010, he was appointed head trader of a team tasked with the orderly disposition of a $100bn+ global portfolio of non-core assets comprised of financial instruments and direct investments. 

Mr Elbied received a diplome d’ingenieur in Applied Mathematics and Computer Science from ENSIMAG (France) and graduated with a MSc in Financial Mathematics from the University of Chicago. 

Mr Elbied has been a CFA charterholder since 2004.

Member Name

Member Position

Member Description